(Q35206255)

English

Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

0 references

1 reference

based on heuristic

inferred from title

10

object named as

John B Fiveash

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

author name string

Grant M Clark

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Andrew M McDonald

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Louis B Nabors

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Hassan Fathalla-Shaykh

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Xiaosi Han

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Christopher D Willey

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

James M Markert

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Barton L Guthrie

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Markus Bredel

9

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

publication date

1 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Neuro-oncology practice

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

172-177

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4369713

28 July 2018

Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4369713

28 July 2018

The role of salvage reirradiation for malignant gliomas that progress on bevacizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4369713

28 July 2018

Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4369713

28 July 2018

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4369713

28 July 2018

Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4369713

28 July 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4369713

28 July 2018

State-of-the-art treatment of high-grade brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4369713

28 July 2018

Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel.

1 reference

https://api.crossref.org/works/10.1093%2FNOP%2FNPU028

21 January 2018

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1093%2FNOP%2FNPU028

21 January 2018

Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial

1 reference

https://api.crossref.org/works/10.1093%2FNOP%2FNPU028

21 January 2018

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

1 reference

https://api.crossref.org/works/10.1093%2FNOP%2FNPU028

21 January 2018

Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival

1 reference

https://api.crossref.org/works/10.1093%2FNOP%2FNPU028

21 January 2018

Irradiation and bevacizumab in high-grade glioma retreatment settings

1 reference

https://api.crossref.org/works/10.1093%2FNOP%2FNPU028

21 January 2018

Identifiers

10.1093/NOP/NPU028

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35206255&oldid=1872314504"